Beauty Health Company (The) - Warrants (04/05/2026) Profit Margin

Beauty Health Company (The) - Warrants (04/05/2026) posts a profit margin of -187.71% as of September 2021. That is below the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a profit margin near 13.89% is typical. Beauty Health Company (The) - Warrants (04/05/2026)'s -187.71% is lower that level. That is roughly 1451.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Beauty Health Company (The) - Warrants (04/05/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -187.71% as of September 2021; use YoY and peer views to separate noise from signal.

Context for SKINW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Beauty Health Company (The) - Warrants (04/05/2026)'s other metric pages and overview cover the third.

Judging Beauty Health Company (The) - Warrants (04/05/2026) against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in profit margin easier to interpret. Start with -187.71% here, then scan peer and history charts to see if the gap is persistent.